Literature DB >> 17047364

Control of amyloid-beta-peptide generation by subcellular trafficking of the beta-amyloid precursor protein and beta-secretase.

Jochen Walter1.   

Abstract

Amyloid-beta (Abeta) peptides are major components of Alzheimer's disease (AD)-associated senile plaques and generated by sequential cleavage of the beta-amyloid precursor protein (betaAPP) by beta-secretase and gamma-secretase. While beta-secretase activity is exerted by the aspartic protease BACE1, gamma-secretase consists of a protein complex of at least four essential proteins with the presenilins as the catalytically active components. The understanding of the subcellular trafficking of betaAPP and proteases involved in its proteolytic processing has increased rapidly in the last years. BetaAPP as well as the secretases are membrane proteins, and recent work demonstrated that alterations in the lipid composition of cellular membranes could affect the proteolytic processing of betaAPP and Abeta generation. We identified glycosphingolipids as membrane components that modulate the subcellular transport of betaAPP and the generation of Abeta. By cell biological and biochemical methods we also characterized the role of BACE1 and its homologue BACE2 in the proteolytic processing of betaAPP. Here, I summarize and discuss these findings in the context of other studies focused on the function of BACE1 and BACE2 and the role of subcellular trafficking in the proteolytic processing of betaAPP. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047364     DOI: 10.1159/000095263

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  6 in total

Review 1.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

Review 2.  Neuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptors.

Authors:  Bor Luen Tang
Journal:  Cell Adh Migr       Date:  2009-01-21       Impact factor: 3.405

3.  Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease.

Authors:  Cai Zhiyou; Yan Yong; Sun Shanquan; Zhang Jun; Huang Liangguo; Yan Ling; Li Jieying
Journal:  Neurochem Res       Date:  2009-01-04       Impact factor: 3.996

4.  Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer's disease patients.

Authors:  Carlos Pomilio; Roxana M Gorojod; Miguel Riudavets; Angeles Vinuesa; Jessica Presa; Amal Gregosa; Melisa Bentivegna; Agustina Alaimo; Soledad Porte Alcon; Gustavo Sevlever; Monica L Kotler; Juan Beauquis; Flavia Saravia
Journal:  Geroscience       Date:  2020-01-23       Impact factor: 7.713

Review 5.  Houshiheisan compound prescription protects neurovascular units after cerebral ischemia.

Authors:  Haizheng Wang; Lei Wang; Nan Zhang; Qi Zhang; Hui Zhao; Qiuxia Zhang
Journal:  Neural Regen Res       Date:  2014-04-01       Impact factor: 5.135

6.  A novel rhamnoside derivative PL402 up-regulates matrix metalloproteinase 3/9 to promote Aβ degradation and alleviates Alzheimer's-like pathology.

Authors:  Tingting Hu; Yue Zhou; Jing Lu; Peng Xia; Yue Chen; Xin Cao; Gang Pei
Journal:  Aging (Albany NY)       Date:  2020-01-05       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.